{"id":18083,"date":"2022-12-09T15:59:22","date_gmt":"2022-12-09T15:59:22","guid":{"rendered":"https:\/\/psychedelichealth.co.uk\/?p=18083"},"modified":"2022-12-09T16:10:47","modified_gmt":"2022-12-09T16:10:47","slug":"ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine","status":"publish","type":"post","link":"https:\/\/psychedelichealth.co.uk\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/","title":{"rendered":"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine"},"content":{"rendered":"<h3 class=\"p1\"><b>Former Red Bull\u00a0Canada\u00a0and Juul Labs Canada\u00a0executive, Nicholas\u00a0Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine.<\/b><\/h3>\n<p class=\"p1\">Kadysh, an expert on regulatory issues, will be Special Advisor for developing MEAI as an alcohol substitute.<\/p>\n<p class=\"p1\">MEAI is <a href=\"https:\/\/www.clearmindmedicine.com\/\" target=\"_blank\" rel=\"noopener\">Clearmind<\/a>\u2019s novel psychedelic-derived drug candidate for treating addictions. However, the company has stated it is also preforming safety studies for MEAI to be deployed as an alcohol substitute.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p class=\"p1\">Clearmind has stated Kadysh brings his expertise in navigating complex regulatory challenges in the health and food industry.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<div style=\"clear:both; margin-top:0em; margin-bottom:1em;\"><a href=\"https:\/\/psychedelichealth.co.uk\/2022\/11\/24\/clinical-trial-psychedelic-candidate-alcohol-addiction\/\" target=\"_blank\" rel=\"dofollow\" class=\"uecd3eeae349046844089bf4068b79b44\"><style> .uecd3eeae349046844089bf4068b79b44 { padding:0px; margin: 0; padding-top:1em!important; padding-bottom:1em!important; width:100%; display: block; font-weight:bold; background-color:#eaeaea; border:0!important; border-left:4px solid #34495E!important; text-decoration:none; } .uecd3eeae349046844089bf4068b79b44:active, .uecd3eeae349046844089bf4068b79b44:hover { opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; text-decoration:none; } .uecd3eeae349046844089bf4068b79b44 { transition: background-color 250ms; webkit-transition: background-color 250ms; opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; } .uecd3eeae349046844089bf4068b79b44 .ctaText { font-weight:bold; color:inherit; text-decoration:none; font-size: 16px; } .uecd3eeae349046844089bf4068b79b44 .postTitle { color:#000000; text-decoration: underline!important; font-size: 16px; } .uecd3eeae349046844089bf4068b79b44:hover .postTitle { text-decoration: underline!important; } <\/style><div style=\"padding-left:1em; padding-right:1em;\"><span class=\"ctaText\">See also<\/span>&nbsp; <span class=\"postTitle\">Clinical trial to investigate psychedelic candidate for alcohol addiction<\/span><\/div><\/a><\/div>\n<p class=\"p1\">Kadysh is the founder of PharmAla Biotech, which manufactures MDMA- and MDXX-class molecules for pharmaceutical research, and the Board Chair of Psychedelics Canada, the trade association for the for-profit, legal Canadian psychedelics industry.<\/p>\n<p class=\"p1\">Clearmind&#8217;s CEO, Dr Adi Zuloff- Shani, commented:<span class=\"Apple-converted-space\">\u00a0 <\/span>&#8220;Nick brings invaluable knowledge of corporate affairs and regulations. We are thrilled to have him join the company and contribute from his vast experience to our alcohol substitute programme.\u201d<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p class=\"p1\">According to NielsenIQ, a global information services company, non-alcoholic beverage sales are growing quickly. Between August 2021 and August 2022, total dollar sales of non-alcoholic drinks in the US stood at $395 million &#8212; a year-on-year growth of approximately 21%.<\/p>\n<p class=\"p1\">Alongside its plans for MEAI as an alcohol substitute, Clearmind announced in November that it was embarking on a first-in-human clinical trial evaluating its proprietary drug candidate CMND-100, which is an MEAI- based molecule, for the treatment of Alcohol Use Disorder (AUD).<\/p>\n<p class=\"p1\">Clearmind has already progressed MEAI through a preliminary drug development route with several studies, and the company has stated that MEAI holds the promise to break vicious binge-drinking cycles by potentially innervating neural pathways such as 5-HT1A, which leads to decreased impulsivity and \u201csensible behaviour\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Former Red Bull\u00a0Canada\u00a0and Juul Labs Canada\u00a0executive, Nicholas\u00a0Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine. Kadysh, an expert on regulatory issues, will be Special Advisor for developing MEAI as an alcohol substitute. MEAI is Clearmind\u2019s novel psychedelic-derived drug candidate for treating addictions. However, the company has stated it is also [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":18084,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_cbd_carousel_blocks":"[]","content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[214],"tags":[184,48,237],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v18.1 (Yoast SEO v22.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ex-Red Bull and Juul exec steps into role at Clearmind Medicine<\/title>\n<meta name=\"description\" content=\"Former Red Bull\u00a0Canada\u00a0and Juul Labs Canada\u00a0executive, Nicholas\u00a0Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine\" \/>\n<meta property=\"og:description\" content=\"Former Red Bull\u00a0Canada\u00a0and Juul Labs Canada\u00a0executive, Nicholas\u00a0Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"Psychedelic Health\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-09T15:59:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-09T16:10:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/34.142.66.208\/wp-content\/uploads\/2022\/12\/Screenshot-2022-12-09-at-16.03.49-1024x682.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"682\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Stephanie Price\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/steph_jprice\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stephanie Price\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/\",\"url\":\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/\",\"name\":\"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/34.142.66.208\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/12\/Screenshot-2022-12-09-at-16.03.49.png\",\"datePublished\":\"2022-12-09T15:59:22+00:00\",\"dateModified\":\"2022-12-09T16:10:47+00:00\",\"author\":{\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\"},\"description\":\"Former Red Bull\u00a0Canada\u00a0and Juul Labs Canada\u00a0executive, Nicholas\u00a0Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine.\",\"breadcrumb\":{\"@id\":\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#primaryimage\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/12\/Screenshot-2022-12-09-at-16.03.49.png\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/12\/Screenshot-2022-12-09-at-16.03.49.png\",\"width\":1604,\"height\":1068,\"caption\":\"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/34.142.66.208\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/34.142.66.208\/#website\",\"url\":\"https:\/\/34.142.66.208\/\",\"name\":\"Psychedelic Health\",\"description\":\"News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/34.142.66.208\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\",\"name\":\"Stephanie Price\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"caption\":\"Stephanie Price\"},\"description\":\"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \\\"Medical Cannabis Explained\\\".\",\"sameAs\":[\"https:\/\/psychedelichealth.co.uk\",\"https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice\"],\"url\":\"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine","description":"Former Red Bull\u00a0Canada\u00a0and Juul Labs Canada\u00a0executive, Nicholas\u00a0Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/","og_locale":"en_GB","og_type":"article","og_title":"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine","og_description":"Former Red Bull\u00a0Canada\u00a0and Juul Labs Canada\u00a0executive, Nicholas\u00a0Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine.","og_url":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/","og_site_name":"Psychedelic Health","article_publisher":"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","article_published_time":"2022-12-09T15:59:22+00:00","article_modified_time":"2022-12-09T16:10:47+00:00","og_image":[{"width":1024,"height":682,"url":"https:\/\/34.142.66.208\/wp-content\/uploads\/2022\/12\/Screenshot-2022-12-09-at-16.03.49-1024x682.png","type":"image\/png"}],"author":"Stephanie Price","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/steph_jprice","twitter_misc":{"Written by":"Stephanie Price","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/","url":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/","name":"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine","isPartOf":{"@id":"https:\/\/34.142.66.208\/#website"},"primaryImageOfPage":{"@id":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#primaryimage"},"image":{"@id":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/12\/Screenshot-2022-12-09-at-16.03.49.png","datePublished":"2022-12-09T15:59:22+00:00","dateModified":"2022-12-09T16:10:47+00:00","author":{"@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12"},"description":"Former Red Bull\u00a0Canada\u00a0and Juul Labs Canada\u00a0executive, Nicholas\u00a0Kadysh, has been appointed to the role of Executive Special Advisor by Clearmind Medicine.","breadcrumb":{"@id":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#primaryimage","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/12\/Screenshot-2022-12-09-at-16.03.49.png","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/12\/Screenshot-2022-12-09-at-16.03.49.png","width":1604,"height":1068,"caption":"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine"},{"@type":"BreadcrumbList","@id":"https:\/\/34.142.66.208\/2022\/12\/09\/ex-red-bull-and-juul-exec-steps-into-role-at-clearmind-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/34.142.66.208\/"},{"@type":"ListItem","position":2,"name":"Ex-Red Bull and Juul exec steps into role at Clearmind Medicine"}]},{"@type":"WebSite","@id":"https:\/\/34.142.66.208\/#website","url":"https:\/\/34.142.66.208\/","name":"Psychedelic Health","description":"News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/34.142.66.208\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12","name":"Stephanie Price","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/image\/","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","caption":"Stephanie Price"},"description":"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \"Medical Cannabis Explained\".","sameAs":["https:\/\/psychedelichealth.co.uk","https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice"],"url":"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/18083"}],"collection":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/comments?post=18083"}],"version-history":[{"count":0,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/18083\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media\/18084"}],"wp:attachment":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media?parent=18083"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/categories?post=18083"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/tags?post=18083"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}